reasons: Unit: Million Baht - The General Patient revenue for Q1/2019 were Baht 1,396.6 million which increased from Q1/2018 by Baht 192.3 million or 16.0% as a result of constantly growing of the existing
June 2017, the net profit was Baht 46.72 million, increased by 9.62 million or increasing by 25.9 percents in which performance for the company and its subsidiaries in the current three-month period
increasing distribution nergy throug sale perform uarter of 2017 collection an percent. Whi 853.4 million subsidiaries the subsidi financial insti 016 Ch MB 4.2 67.6 7.2 33.4 3.8 448.3 9.1 39.7 4.7 13.4 6.4
December compared to last year and we see this continuing into the first quarter of 2018. The year as a whole was focused on increasing topline growth which has been achieved with a 115mTHB or +14% increase
in public buses, and fleet trucks by price subsidies on B20 to be lower than B7 by 3 Baht/liter through State Oil Fund, more encouraging public to use B20 by increasing price subsidies on B20 from 3
government has announced various measurements ,which attributed to increasing of methyl ester and crude palm oil demand in Thailand. For natural fatty alcohols market, in 2Q/2019, it was better than 2Q/2018
quarter of year 2019 increased 44.40 and 38.21 percent from the same period of last year. Main attribution is increasing in sales quantities from 2nd production line. However, continuously decreasing in
store in Ratchaburi province in August 2019, the Company plans to open the second store in the second half of 2020. Continuously expanding overseas stores After receiving impressive feedback from the
growth for the commercial vehicle segment and the passenger car segment growing at 3.8% and 25.0% respectively comparing to the same period last year. The high increased for the passenger car segment
expan om 34% in 2Q16 GB/data sub/m growing 4G ad with expanded major players ration, AIS has llows us to aigns were offe subscriptions. broadband and or video stream tinued to impr nvironment